Create Medic Co., Ltd.

TSE:5187.T

972 (JPY) • At close July 30, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) JPY.

202420232022202120202019201820172016201520142013201220112010200920082007200620052004
Revenue 13,030.32212,585.44912,257.29411,698.68210,830.47110,843.96110,796.96410,393.56310,003.0039,650.7029,939.7999,880.6179,331.9159,325.3689,097.3599,017.6969,058.888,878.4838,439.8358,488.318,219.693
Cost of Revenue 7,326.1547,107.1096,882.7796,438.4645,752.7015,615.6835,753.1275,471.2625,499.9625,438.9775,684.4315,502.2295,025.7994,822.4444,484.1194,414.0434,359.5564,432.793,826.2743,863.054,171.811
Gross Profit 5,704.1685,478.345,374.5155,260.2185,077.775,228.2785,043.8374,922.3014,503.0414,211.7254,255.3684,378.3884,306.1164,502.9244,613.244,603.6534,699.3244,445.6934,613.5614,625.264,047.882
Gross Profit Ratio 0.4380.4350.4380.450.4690.4820.4670.4740.450.4360.4280.4430.4610.4830.5070.5110.5190.5010.5470.5450.492
Reseach & Development Expenses 0850882.093785.74630.241637.198616.612506.151362.922281.326250285358354.777447.682410.177441.828431.836436.362455.49467.69
General & Administrative Expenses 000000000000000000000
Selling & Marketing Expenses 000000000000000000000
SG&A 5,0113,824.6553,754.713,607.6933,462.7073,507.6513,433.3653,562.1443,385.8413,282.2413,4713,5533,5663,146.8362,934.4382,916.232,823.932,778.8782,730.5462,607.1312,342.959
Other Expenses 0.7120.3450000000-0.001-249.86-284.266-357.651-0.0010-0.00100000
Operating Expenses 5,011.7124,6754,636.8034,393.4334,092.9484,144.8494,049.9774,068.2953,748.7633,563.5663,471.143,553.7343,566.3493,501.6123,382.123,326.4063,265.7583,210.7143,166.9083,062.6212,810.649
Operating Income 692.456803.244737.711866.784984.8211,083.427993.859854.006754.277648.158784.227824.654739.7651,001.3111,231.121,277.2461,433.5651,234.9791,446.6531,562.6391,237.233
Operating Income Ratio 0.0530.0640.060.0740.0910.10.0920.0820.0750.0670.0790.0830.0790.1070.1350.1420.1580.1390.1710.1840.151
Total Other Income Expenses Net 394.371100.782122.02898.842-0.43218.152-13.691-84.6153.166-28.90343.2670.216178.73251.054-116.33-175.28-118.608-3.0516.0346.47224.405
Income Before Tax 1,086.827904.024863.039965.626984.3891,101.579980.168769.396807.443619.255827.487894.87918.4971,052.3651,114.791,101.9661,314.9571,231.9291,462.6871,569.1111,261.638
Income Before Tax Ratio 0.0830.0720.070.0830.0910.1020.0910.0740.0810.0640.0830.0910.0980.1130.1230.1220.1450.1390.1730.1850.153
Income Tax Expense 245.925750.001380.826305.217324.866376.525307.631301.434290.748286.111337.427361.241406.225468.983447.248476.469504.63476.926561.793612.106558.606
Net Income 840.901154.022482.213660.409659.523725.054672.536467.961516.695333.143490.059533.628512.271583.382667.541625.496810.326755.003900.894957.005703.032
Net Income Ratio 0.0650.0120.0390.0560.0610.0670.0620.0450.0520.0350.0490.0540.0550.0630.0730.0690.0890.0850.1070.1130.086
EPS 95.3116.925372.6171.1977.8372.250.2354.7334.6450.9655.4953.2760.6669.4165.0484.2678.593.6698.1771.8
EPS Diluted 95.3116.925372.6171.1977.8372.250.2354.7334.6450.9655.4953.2760.6669.4165.0484.2678.593.6698.1771.8
EBITDA 1,733.9051,503.1511,474.9921,434.1931,397.5791,499.5431,335.8411,127.8961,152.398951.2381,189.8541,216.2721,209.771,305.3091,357.9131,389.1321,624.9751,559.7761,786.2661,884.9421,565.547
EBITDA Ratio 0.1330.1190.120.1230.1290.1380.1240.1090.1150.0990.120.1230.130.140.1490.1540.1790.1760.2120.2220.19